Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

The Monitoring and Evaluation of a Multicountry Surveillance Study, the Severe Typhoid Fever in Africa Program.

Mogeni OD, Cruz Espinoza LM, Im J, Panzner U, Toy T, Pak GD, Haselbeck A, Ramani E, Schütt-Gerowitt H, Jacobs J, Metila OL, Adewusi OJ, Okeke IN, Ogunleye VI, Owusu-Dabo E, Rakotozandrindrainy R, Soura AB, Teferi M, Roy KC, Macwright W, Breiman RF, Kim JH, Mogasale V, Baker S, Park SE, Marks F.

Clin Infect Dis. 2019 Oct 30;69(Supplement_6):S510-S518. doi: 10.1093/cid/ciz597.

2.

The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis.

Park SE, Toy T, Cruz Espinoza LM, Panzner U, Mogeni OD, Im J, Poudyal N, Pak GD, Seo H, Chon Y, Schütt-Gerowitt H, Mogasale V, Ramani E, Dey A, Park JY, Kim JH, Seo HJ, Jeon HJ, Haselbeck A, Conway Roy K, MacWright W, Adu-Sarkodie Y, Owusu-Dabo E, Osei I, Owusu M, Rakotozandrindrainy R, Soura AB, Kabore LP, Teferi M, Okeke IN, Kehinde A, Popoola O, Jacobs J, Lunguya Metila O, Meyer CG, Crump JA, Elias S, Maclennan CA, Parry CM, Baker S, Mintz ED, Breiman RF, Clemens JD, Marks F.

Clin Infect Dis. 2019 Oct 30;69(Supplement_6):S422-S434. doi: 10.1093/cid/ciz715.

3.

Bacteremia Among Febrile Patients Attending Selected Healthcare Facilities in Ibadan, Nigeria.

Popoola O, Kehinde A, Ogunleye V, Adewusi OJ, Toy T, Mogeni OD, Aroyewun EO, Agbi S, Adekanmbi O, Adepoju A, Muyibi S, Adebiyi I, Elaturoti OO, Nwimo C, Adeoti H, Omotosho T, Akinlabi OC, Adegoke PA, Adeyanju OA, Panzner U, Baker S, Park SE, Marks F, Okeke IN.

Clin Infect Dis. 2019 Oct 30;69(Supplement_6):S466-S473. doi: 10.1093/cid/ciz516.

4.

How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines?

Jeon HJ, Im J, Haselbeck A, Holm M, Rakotozandrindrainy R, Bassiahi AS, Panzner U, Mogeni OD, Seo HJ, Lunguya O, Jacobs J, Okeke IN, Terferi M, Owusu-Dabo E, Dougan G, Carey M, Steele AD, Kim JH, Clemens JD, Andrews JR, Park SE, Baker S, Marks F.

Clin Infect Dis. 2019 Oct 30;69(Supplement_6):S417-S421. doi: 10.1093/cid/ciz629.

5.

Improving the estimation of the global burden of antimicrobial resistant infections.

Limmathurotsakul D, Dunachie S, Fukuda K, Feasey NA, Okeke IN, Holmes AH, Moore CE, Dolecek C, van Doorn HR, Shetty N, Lopez AD, Peacock SJ; Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC).

Lancet Infect Dis. 2019 Nov;19(11):e392-e398. doi: 10.1016/S1473-3099(19)30276-2. Epub 2019 Aug 16. Review.

PMID:
31427174
6.

Cross-cultural adaptation and validation of the reintegration to normal living index into IGBO language among individuals with mobility disability.

Okoye EC, Oyedum SO, Akosile CO, Onwuakagba IU, Ibikunle PO, Okonkwo UP, Okeke IA.

J Patient Rep Outcomes. 2019 Jul 12;3(1):40. doi: 10.1186/s41687-019-0139-9.

7.

Antimicrobial resistance of Vibrio cholerae from sub-Saharan Africa: A systematic review.

Mohammed Y, Aboderin AO, Okeke IN, Olayinka AT.

Afr J Lab Med. 2018 Dec 6;7(2):778. doi: 10.4102/ajlm.v7i2.778. eCollection 2018. Review.

8.

The HPAfrica protocol: Assessment of health behaviour and population-based socioeconomic, hygiene behavioural factors - a standardised repeated cross-sectional study in multiple cohorts in sub-Saharan Africa.

Pak GD, Haselbeck AH, Seo HW, Osei I, Amuasi J, Breiman RF, Cruz Espinosa LM, Holm M, Im J, Jang GH, Jeon HJ, Luby SP, Lunguya-Metila O, MacWright W, Mogeni OD, Okeke IN, Owusu-Dabo E, Park JK, Park SE, Popoola O, Seo HJ, Soura AB, Teferi M, Toy T, Chon Y, Rafindrakalia M, Rakotozandrindrainy R, Meyer CG, Marks F, Panzner U.

BMJ Open. 2018 Dec 19;8(12):e021438. doi: 10.1136/bmjopen-2017-021438.

9.

Antimicrobial resistance surveillance in Africa: Successes, gaps and a roadmap for the future.

Kariuki S, Keddy KH, Antonio M, Okeke IN.

Afr J Lab Med. 2018 Dec 6;7(2):924. doi: 10.4102/ajlm.v7i2.924. eCollection 2018. No abstract available.

10.

Building resources to meet evolving laboratory medicine challenges in Africa.

Okeke IN.

Afr J Lab Med. 2018 Nov 29;7(1):915. doi: 10.4102/ajlm.v7i1.915. eCollection 2018. No abstract available.

11.

Harnessing alternative sources of antimicrobial resistance data to support surveillance in low-resource settings.

Ashley EA, Shetty N, Patel J, van Doorn R, Limmathurotsakul D, Feasey NA, Okeke IN, Peacock SJ.

J Antimicrob Chemother. 2019 Mar 1;74(3):541-546. doi: 10.1093/jac/dky487.

12.

Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action.

Fukuda K, Limmathurotsakul D, Okeke IN, Shetty N, van Doorn R, Feasey NA, Chiara F, Zoubiane G, Jinks T, Parkhill J, Patel J, Reid SWJ, Holmes AH, Peacock SJ; Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC).

Wellcome Open Res. 2018 May 16;3:59. doi: 10.12688/wellcomeopenres.14586.2. eCollection 2018.

13.

Correction: Classes 1 and 2 integrons in faecal Escherichia coli strains isolated from mother-child pairs in Nigeria.

Odetoyin BW, Labar AS, Lamikanra A, Aboderin AO, Okeke IN.

PLoS One. 2018 May 7;13(5):e0197202. doi: 10.1371/journal.pone.0197202. eCollection 2018.

14.

Aggregative Adherence and Intestinal Colonization by Enteroaggregative Escherichia coli Are Produced by Interactions among Multiple Surface Factors.

Blanton LV, Wang LT, Hofmann J, DuBow J, Lafrance A, Kwak S, Bowers L, Levine MA, Hale CO, Meneely PM, Okeke IN.

mSphere. 2018 Mar 21;3(2). pii: e00078-18. doi: 10.1128/mSphere.00078-18. eCollection 2018 Mar-Apr.

15.

Honing in on disease etiology.

Okeke IN.

Afr J Lab Med. 2017 Dec 8;6(1):679. doi: 10.4102/ajlm.v6i1.679. eCollection 2017. No abstract available.

16.

Laboratory systems as an antibacterial resistance containment tool in Africa.

Okeke IN.

Afr J Lab Med. 2016 Oct 31;5(3):497. doi: 10.4102/ajlm.v5i3.497. eCollection 2016. Review.

17.

Classes 1 and 2 integrons in faecal Escherichia coli strains isolated from mother-child pairs in Nigeria.

Odetoyin BW, Labar AS, Lamikanra A, Aboderin AO, Okeke IN.

PLoS One. 2017 Aug 22;12(8):e0183383. doi: 10.1371/journal.pone.0183383. eCollection 2017. Erratum in: PLoS One. 2018 May 7;13(5):e0197202.

18.

Characterization of a Large Antibiotic Resistance Plasmid Found in Enteropathogenic Escherichia coli Strain B171 and Its Relatedness to Plasmids of Diverse E. coli and Shigella Strains.

Hazen TH, Michalski J, Nagaraj S, Okeke IN, Rasko DA.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00995-17. doi: 10.1128/AAC.00995-17. Print 2017 Sep.

19.

Broadening Participation in the Sciences within and from Africa: Purpose, Challenges, and Prospects.

Okeke IN, Babalola CP, Byarugaba DK, Djimde A, Osoniyi OR.

CBE Life Sci Educ. 2017 Summer;16(2). pii: es2. doi: 10.1187/cbe.15-12-0265.

20.

Bovine tuberculosis: a retrospective study at Jos abattoir, Plateau State, Nigeria.

Okeke LA, Fawole O, Muhammad M, Okeke IO, Nguku P, Wasswa P, Dairo D, Cadmus S.

Pan Afr Med J. 2016 Nov 29;25:202. doi: 10.11604/pamj.2016.25.202.5669. eCollection 2016.

21.

Negative Marking and the Student Physician--A Descriptive Study of Nigerian Medical Schools.

Ndu IK, Ekwochi U, Di Osuorah C, Asinobi IN, Nwaneri MO, Uwaezuoke SN, Amadi OF, Okeke IB, Chinawa JM, Orjioke CJG.

J Med Educ Curric Dev. 2016 Nov 13;3. pii: JMECD.S40705. doi: 10.4137/JMECD.S40705. eCollection 2016 Jan-Dec.

22.

Injectable porous nano-hydroxyapatite/chitosan/tripolyphosphate scaffolds with improved compressive strength for bone regeneration.

Uswatta SP, Okeke IU, Jayasuriya AC.

Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:505-12. doi: 10.1016/j.msec.2016.06.089. Epub 2016 Jun 28.

23.

Self-association motifs in the enteroaggregative Escherichia coli heat-resistant agglutinin 1.

Glaubman J, Hofmann J, Bonney ME, Park S, Thomas JM, Kokona B, Ramos Falcón LI, Chung YK, Fairman R, Okeke IN.

Microbiology. 2016 Jul;162(7):1091-1102. doi: 10.1099/mic.0.000303. Epub 2016 May 10.

PMID:
27166217
24.

Fluoroquinolone-Resistant Enteric Bacteria in Sub-Saharan Africa: Clones, Implications and Research Needs.

Chattaway MA, Aboderin AO, Fashae K, Okoro CK, Opintan JA, Okeke IN.

Front Microbiol. 2016 Apr 22;7:558. doi: 10.3389/fmicb.2016.00558. eCollection 2016. Review.

25.

Enteroinvasive Escherichia coli May Account for Uncultured Shigella.

Okeke IN, Aboderin AO, Opintan JA.

Am J Trop Med Hyg. 2016 Feb;94(2):480-481. doi: 10.4269/ajtmh.15-0777a. No abstract available.

26.

Diarrhoeagenic Escherichia coli in mother-child Pairs in Ile-Ife, South Western Nigeria.

Odetoyin BW, Hofmann J, Aboderin AO, Okeke IN.

BMC Infect Dis. 2016 Jan 25;16:28. doi: 10.1186/s12879-016-1365-x.

27.

Danger Signs of Childhood Pneumonia: Caregiver Awareness and Care Seeking Behavior in a Developing Country.

Ndu IK, Ekwochi U, Osuorah CD, Onah KS, Obuoha E, Odetunde OI, Nwokoye I, Obumneme-Anyim NI, Okeke IB, Amadi OF.

Int J Pediatr. 2015;2015:167261. doi: 10.1155/2015/167261. Epub 2015 Oct 21.

28.

Delays in healthcare delivery to sick neonates in Enugu South-East Nigeria: an analysis of causes and effects.

Ekwochi U, Ndu IK, Osuorah CD, Onah KS, Obuoha E, Odetunde OI, Nwokoye I, Obumneme-Anyim NI, Okeke IB, Amadi OF.

J Public Health (Oxf). 2016 Jun;38(2):e171-7. doi: 10.1093/pubmed/fdv092. Epub 2015 Jul 21.

PMID:
26201350
29.

Knowledge of danger signs in newborns and health seeking practices of mothers and care givers in Enugu state, South-East Nigeria.

Ekwochi U, Ndu IK, Osuorah CD, Amadi OF, Okeke IB, Obuoha E, Onah KS, Nwokoye I, Odetunde OI, Obumneme-Anyim NI.

Ital J Pediatr. 2015 Mar 21;41:18. doi: 10.1186/s13052-015-0127-5.

30.

Enteroaggregative Escherichia coli have evolved independently as distinct complexes within the E. coli population with varying ability to cause disease.

Chattaway MA, Jenkins C, Rajendram D, Cravioto A, Talukder KA, Dallman T, Underwood A, Platt S, Okeke IN, Wain J.

PLoS One. 2014 Nov 21;9(11):e112967. doi: 10.1371/journal.pone.0112967. eCollection 2014.

31.

Dissemination of the transmissible quinolone-resistance gene qnrS1 by IncX plasmids in Nigeria.

Sumrall ET, Gallo EB, Aboderin AO, Lamikanra A, Okeke IN.

PLoS One. 2014 Oct 23;9(10):e110279. doi: 10.1371/journal.pone.0110279. eCollection 2014.

32.

Prevalence and risk factors of Mycobacterium tuberculosis complex infection in slaughtered cattle at Jos South Abattoir, Plateau State, Nigeria.

Okeke LA, Cadmus S, Okeke IO, Muhammad M, Awoloh O, Dairo D, Waziri EN, Olayinka A, Nguku PM, Fawole O.

Pan Afr Med J. 2014 Jul 21;18 Suppl 1:7. doi: 10.11694/pamj.supp.2014.18.1.3841. eCollection 2014.

33.

Diagnostic schemes for reducing epidemic size of African viral hemorrhagic fever outbreaks.

Okeke IN, Manning RS, Pfeiffer T.

J Infect Dev Ctries. 2014 Sep 12;8(9):1148-59. doi: 10.3855/jidc.4636.

34.

Comparative genomics of 274 Vibrio cholerae genomes reveals mobile functions structuring three niche dimensions.

Dutilh BE, Thompson CC, Vicente AC, Marin MA, Lee C, Silva GG, Schmieder R, Andrade BG, Chimetto L, Cuevas D, Garza DR, Okeke IN, Aboderin AO, Spangler J, Ross T, Dinsdale EA, Thompson FL, Harkins TT, Edwards RA.

BMC Genomics. 2014 Aug 5;15:654. doi: 10.1186/1471-2164-15-654.

35.

Epidemiology of rotavirus diarrhea among children younger than 5 years in Enugu, South East, Nigeria.

Tagbo BN, Mwenda JM, Armah G, Obidike EO, Okafor UH, Oguonu T, Ozumba UC, Eke CB, Chukwubuike C, Edelu BO, Ezeonwu BU, Amadi O, Okeke IB, Nnani OR, Ani OS, Ugwuezeonu I, Benjamin-Pujah C, Umezinne N, Ude N, Nwodo C, Ezeonyebuchi MC, Umesie E, Okafor V, Ogude N, Osarogborum VO, Ezebilo SK, Goitom WG, Abanida EA, Elemuwa C, Nwagbo DF.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S19-22. doi: 10.1097/INF.0000000000000047.

PMID:
24343608
36.

Antibiotics for uncomplicated severe malnutrition.

Okeke IN, Cruz JR, Keusch GT; Alliance for the Prudent Use of Antibiotics–Nutrition Group.

N Engl J Med. 2013 Jun 20;368(25):2435-6. doi: 10.1056/NEJMc1304407. No abstract available.

PMID:
23782190
37.

Cholera outbreaks in Nigeria are associated with multidrug resistant atypical El Tor and non-O1/non-O139 Vibrio cholerae.

Marin MA, Thompson CC, Freitas FS, Fonseca EL, Aboderin AO, Zailani SB, Quartey NK, Okeke IN, Vicente AC.

PLoS Negl Trop Dis. 2013;7(2):e2049. doi: 10.1371/journal.pntd.0002049. Epub 2013 Feb 14.

38.

Regional dissemination of a trimethoprim-resistance gene cassette via a successful transposable element.

Labar AS, Millman JS, Ruebush E, Opintan JA, Bishar RA, Aboderin AO, Newman MJ, Lamikanra A, Okeke IN.

PLoS One. 2012;7(5):e38142. doi: 10.1371/journal.pone.0038142. Epub 2012 May 30.

39.

Prolonged febrile illness due to CTX-M-15 extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection in Nigeria.

Aboderin OA, Adefehinti O, Odetoyin BW, Olotu AA, Okeke IN, Adeodu OO.

Afr J Lab Med. 2012 Jun 4;1(1):16. doi: 10.4102/ajlm.v1i1.16. eCollection 2012.

40.

Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use.

Lamikanra A, Crowe JL, Lijek RS, Odetoyin BW, Wain J, Aboderin AO, Okeke IN.

BMC Infect Dis. 2011 Nov 7;11:312. doi: 10.1186/1471-2334-11-312.

41.

Vibrio cholerae O1 lineages driving cholera outbreaks during seventh cholera pandemic in Ghana.

Thompson CC, Freitas FS, Marin MA, Fonseca EL, Okeke IN, Vicente AC.

Infect Genet Evol. 2011 Dec;11(8):1951-6. doi: 10.1016/j.meegid.2011.08.020. Epub 2011 Aug 30.

42.

The heat-resistant agglutinin family includes a novel adhesin from enteroaggregative Escherichia coli strain 60A.

Mancini J, Weckselblatt B, Chung YK, Durante JC, Andelman S, Glaubman J, Dorff JD, Bhargava S, Lijek RS, Unger KP, Okeke IN.

J Bacteriol. 2011 Sep;193(18):4813-20. doi: 10.1128/JB.05142-11. Epub 2011 Jul 15.

43.

Biomedical loopholes, distrusted state, and the politics of HIV/AIDS "cure" in Nigeria.

Obadare E, Okeke IN.

Afr Aff (Lond). 2011;110(439):191-211.

PMID:
21755637
44.

Enteroaggregative E. coli O104 from an outbreak of HUS in Germany 2011, could it happen again?

Chattaway MA, Dallman T, Okeke IN, Wain J.

J Infect Dev Ctries. 2011 Jul 4;5(6):425-36. Review.

45.

Non-prescription antimicrobial use worldwide: a systematic review.

Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S.

Lancet Infect Dis. 2011 Sep;11(9):692-701. doi: 10.1016/S1473-3099(11)70054-8. Epub 2011 Jun 12. Review.

46.

IS3 profiling identifies the enterohaemorrhagic Escherichia coli O-island 62 in a distinct enteroaggregative E. coli lineage.

Okeke IN, Macfarlane-Smith LR, Fletcher JN, Snelling AM.

Gut Pathog. 2011 Mar 30;3:4. doi: 10.1186/1757-4749-3-4.

47.

Diagnostics as essential tools for containing antibacterial resistance.

Okeke IN, Peeling RW, Goossens H, Auckenthaler R, Olmsted SS, de Lavison JF, Zimmer BL, Perkins MD, Nordqvist K.

Drug Resist Updat. 2011 Apr;14(2):95-106. doi: 10.1016/j.drup.2011.02.002. Epub 2011 Mar 12. Review.

PMID:
21398170
48.

Quinolone resistance in Escherichia coli from Accra, Ghana.

Namboodiri SS, Opintan JA, Lijek RS, Newman MJ, Okeke IN.

BMC Microbiol. 2011 Feb 27;11:44. doi: 10.1186/1471-2180-11-44.

49.

Drug Resistance.

Laxminarayan R, Bhutta Z, Duse A, Jenkins P, O'Brien T, Okeke IN, Pablo-Mendez A, Klugman KP.

In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 55.

50.

Multi-locus sequence typing of enteroaggregative Escherichia coli isolates from Nigerian children uncovers multiple lineages.

Okeke IN, Wallace-Gadsden F, Simons HR, Matthews N, Labar AS, Hwang J, Wain J.

PLoS One. 2010 Nov 23;5(11):e14093. doi: 10.1371/journal.pone.0014093.

Supplemental Content

Support Center